Sean X. Luo

679 total citations
30 papers, 418 citations indexed

About

Sean X. Luo is a scholar working on Public Health, Environmental and Occupational Health, Epidemiology and Psychiatry and Mental health. According to data from OpenAlex, Sean X. Luo has authored 30 papers receiving a total of 418 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Public Health, Environmental and Occupational Health, 12 papers in Epidemiology and 6 papers in Psychiatry and Mental health. Recurrent topics in Sean X. Luo's work include Opioid Use Disorder Treatment (13 papers), Substance Abuse Treatment and Outcomes (11 papers) and Attention Deficit Hyperactivity Disorder (5 papers). Sean X. Luo is often cited by papers focused on Opioid Use Disorder Treatment (13 papers), Substance Abuse Treatment and Outcomes (11 papers) and Attention Deficit Hyperactivity Disorder (5 papers). Sean X. Luo collaborates with scholars based in United States, China and Russia. Sean X. Luo's co-authors include L. F. Abbott, Richard Axel, Frances R. Levin, Edward V. Nunes, Joshua R. Steinerman, Brian M. Iacoviello, Nicholas J. Schork, John J. Mariani, John Rotrosen and Kara E. Rudolph and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and American Journal of Psychiatry.

In The Last Decade

Sean X. Luo

29 papers receiving 405 citations

Peers

Countries citing papers authored by Sean X. Luo

Since Specialization

Citations

This map shows the geographic impact of Sean X. Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sean X. Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sean X. Luo more than expected).

Fields of papers citing papers by Sean X. Luo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sean X. Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sean X. Luo. The network helps show where Sean X. Luo may publish in the future.

Co-authorship network of co-authors of Sean X. Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Sean X. Luo. A scholar is included among the top collaborators of Sean X. Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sean X. Luo. Sean X. Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Risks of returning to opioid use at treatment entry and early in opioid use disorder treatment: Role of non-opioid substances 2023 ·Drug and Alcohol Dependence ·Felipe Castillo, Mei‐Chen Hu, Ying Liu, Raymond R. Balise, Roger D. Weiss, John Rotrosen, Edward V. Nunes, Andrew J. Saxon, Daniel J. Feaster, Sean X. Luo	2
2	Estimating the impact of stimulant use on initiation of buprenorphine and extended-release naltrexone in two clinical trials and real-world populations 2023 ·Addiction Science & Clinical Practice ·Ryan Cook, (unknown), Onyebuchi A. Arah, Keith Humphreys, Kara E. Rudolph, Sean X. Luo, Judith I. Tsui, Ximena A. Levander, P. Todd Korthuis	10
3	Immune checkpoint inhibitors related respiratory disorders in patients with lung cancer: A meta-analysis of randomized controlled trials 2023 ·Frontiers in Immunology ·Han Liu, Sean X. Luo, Jing Jie, Liping Peng, Shuai Wang, (unknown)	5
4	Treatment of abdominal aortic pseudoaneurysm caused by brucellosis with endovascular aneurysm repair 2023 ·Frontiers in Bioengineering and Biotechnology ·(unknown), Qilong Wang, Yang Zhang, (unknown), H. Yin, Hua Zhang, Sean X. Luo, Zhongying Wang, Qi Yu, (unknown), Zhihua Cheng	1
5	Buprenorphine & methadone dosing strategies to reduce risk of relapse in the treatment of opioid use disorder 2022 ·Drug and Alcohol Dependence ·Kara E. Rudolph, (unknown), (unknown), Matisyahu Shulman, Marc Fishman, Iván Díaz, Sean X. Luo, John Rotrosen, Edward V. Nunes	10
6	Under-representation of key demographic groups in opioid use disorder trials 2022 ·SHILAP Revista de lepidopterología ·Kara E. Rudolph, Matthew B. Russell, Sean X. Luo, John Rotrosen, Edward V. Nunes	8
7	Specific polysubstance use patterns predict relapse among patients entering opioid use disorder treatment 2022 ·SHILAP Revista de lepidopterología ·Yue Pan, Daniel J. Feaster, Gabriel Odom, Laura A. Brandt, Mei‐Chen Hu, Roger D. Weiss, John Rotrosen, Andrew J. Saxon, Sean X. Luo, Raymond R. Balise	9
8	Optimizing opioid use disorder treatment with naltrexone or buprenorphine 2021 ·Drug and Alcohol Dependence ·Kara E. Rudolph, Iván Díaz, Sean X. Luo, John Rotrosen, Edward V. Nunes	8
9	Digital Clinical Trials for Substance Use Disorders in the Age of Covid-19 2020 ·Journal of Addiction Medicine ·Christina Brezing, Sean X. Luo, John J. Mariani, Frances R. Levin	13
10	Secondary Analysis of Pain Outcomes in a Large Pragmatic Randomized Trial of Buprenorphine/Naloxone Versus Methadone for Opioid Use Disorder 2020 ·Journal of Addiction Medicine ·Matisyahu Shulman, Sean X. Luo, Aimee Campbell, Jennifer Scodes, Martina Pavlicová, (unknown), Andrew J. Saxon, Edward V. Nunes	12
11	Differential Posttreatment Outcomes of Methylphenidate for Smoking Cessation for Individuals With ADHD 2019 ·American Journal on Addictions ·Sean X. Luo, Lirio S. Covey, Mei‐Chen Hu, Theresa Winhusen, Edward V. Nunes	2
12	Trends in MD/PhD Graduates Entering Psychiatry: Assessing the Physician-Scientist Pipeline 2018 ·Academic Psychiatry ·Melissa R. Arbuckle, Sean X. Luo, Harold Alan Pincus, Joshua A. Gordon, Joyce Y. Chung, Mark Chavez, María A. Oquendo	4
13	Clickotine, A Personalized Smartphone App for Smoking Cessation: Initial Evaluation 2017 ·JMIR mhealth and uhealth ·Brian M. Iacoviello, Joshua R. Steinerman, (unknown), (unknown), (unknown), Sean X. Luo, Nicholas J. Schork	90
14	Identification of Driver Genes and Key Pathways of Pediatric Brain Tumors and Comparison of Molecular Pathogenesis Based on Pathologic Types 2017 ·World Neurosurgery ·Sheng Zhong, Bo Wu, (unknown), (unknown), Yang Liu, Sean X. Luo, (unknown), Huimao Zhang, Gang Zhao	5
15	Identification of Driver Genes and Key Pathways of Glioblastoma Shows JNJ-7706621 as a Novel Antiglioblastoma Drug 2017 ·World Neurosurgery ·Sheng Zhong, Bo Wu, Xuechao Dong, (unknown), Shanshan Jiang, Ying Zhang, Yang Bai, Sean X. Luo, Yong Chen, Huimao Zhang, (unknown)	15
16	Towards Precision Addiction Treatment: New Findings in Co-morbid Substance Use and Attention-Deficit Hyperactivity Disorders 2017 ·Current Psychiatry Reports ·Sean X. Luo, Frances R. Levin	22
17	Surgical treatment of syphilitic superficial femoral artery aneurysm: a rare case report 2015 ·BMC Infectious Diseases ·Zhihua Cheng, Sean X. Luo, (unknown), (unknown), Zhongying Wang, Yuzhu Jiang, Zhiyuan An, Qi Wang	2
18	Toward personalized smoking-cessation treatment: Using a predictive modeling approach to guide decisions regarding stimulant medication treatment of attention-deficit/hyperactivity disorder (ADHD) in smokers 2015 ·American Journal on Addictions ·Sean X. Luo, Lirio S. Covey, Mei‐Chen Hu, Frances R. Levin, Edward V. Nunes, Theresa Winhusen	6
19	Multimodal predictive modeling of individual treatment outcome in cocaine dependence with combined neuroimaging and behavioral predictors 2014 ·Drug and Alcohol Dependence ·Sean X. Luo, Diana Martínez, Kenneth M. Carpenter, Mark Slifstein, Edward V. Nunes	18
20	Generating sparse and selective third-order responses in the olfactory system of the fly 2010 ·Proceedings of the National Academy of Sciences ·Sean X. Luo, Richard Axel, L. F. Abbott	100

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact